Biosensia

Biosensia is a science-focused, venture capital-backed enterprise dedicated to developing and leveraging its novel proprietary technology, RapiPlex. RapiPlex is a point-of-care diagnostic system based on a set of proprietary technologies capable of delivering quantitative and qualitative laboratory-quality test results.RapiPlex includes a disposable assay cartridge and a compact benchtop instrument, enabling the shift of complex immunoassays from centralized reference laboratories to doctors' offices or patients' bedside, facilitating patient care without compromising analytical performance. The company possesses core expertise in immunology, biochemistry, microbiology, physics, microfluidics, design engineering, software development, and quality regulatory affairs.